Regeneron Pharmaceuticals
REGN
REGN
670 hedge funds and large institutions have $27.1B invested in Regeneron Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 111 funds opening new positions, 226 increasing their positions, 222 reducing their positions, and 81 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.53% less ownership
Funds ownership: 69.48% → 68.96% (-0.53%)
9% less capital invested
Capital invested by funds: $29.8B → $27.1B (-$2.65B)
24% less call options, than puts
Call options by funds: $755M | Put options by funds: $994M
Holders
670
Holding in Top 10
15
Calls
$755M
Puts
$994M
Top Buyers
| 1 | +$241M | |
| 2 | +$124M | |
| 3 | +$87.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$63M |
| 5 |
D.E. Shaw & Co
New York
|
+$58.6M |
Top Sellers
| 1 | -$399M | |
| 2 | -$226M | |
| 3 | -$78.8M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$69.1M |
| 5 |
O
OrbiMed
New York
|
-$64.4M |